News
The FDA called for Sarepta Therapeutics to stop shipping its muscular dystrophy gene therapy, but the company said no.
Drugmaker Sarepta Therapeutics says it won’t comply with a request from U.S. regulators to halt all shipments of its gene ...
Fox News senior medical analyst Dr. Marc Siegel comments on JUUL use and a recent study on screen time and depression on ‘Fox ...
It's important to stay informed about recalls, because doing so truly impacts your life. Of course, the sooner you know about ...
The FDA has issued a voluntary recall of over 67,000 cases of Power Stick roll-on deodorants due to deviations from ...
FDA outlines both short-term and long-term goals within the letter. In the short term, FDA plans to create a “centralized, ...
Explore more
More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.
On July 14, 2025, the U.S. Food and Drug Administration (FDA) announced an extension to the public comment period for its ...
According to the FDA, millions of people in the U.S. have food allergies or food sensitivities. Food sensitivities can range from mild reactions to potentially life-threatening symptoms. The agency ...
The products were sold nationwide, including by such retailers as Walmart and Amazon. There has been no word of injuries ...
Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.
‘Mother of All Models,’ 60, Stuns on Roman Holiday After Health Setbacks first appeared on Parade on Jul 19, 2025 This story ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results